Our letter aims to discuss the possible mechanisms underlying this finding and understand whether decreased expression of OAS1 might be linked to presence and persistence of anosmia in patients affected from COVID-19-related smell alteration.

OAS1 gene, spike protein variants and persistent COVID-19-related anosmia: may the olfactory disfunction be a harbinger of future neurodegenerative disease? / Di Stadio, A.; Bernitsas, E.; Ralli, M.; Severini, C.; Brenner, M. J.; Angelini, C.. - In: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES. - ISSN 1128-3602. - 26:2(2022), pp. 347-349. [10.26355/eurrev_202201_27858]

OAS1 gene, spike protein variants and persistent COVID-19-related anosmia: may the olfactory disfunction be a harbinger of future neurodegenerative disease?

Di Stadio A.
Primo
;
Ralli M.;
2022

Abstract

Our letter aims to discuss the possible mechanisms underlying this finding and understand whether decreased expression of OAS1 might be linked to presence and persistence of anosmia in patients affected from COVID-19-related smell alteration.
File allegati a questo prodotto
File Dimensione Formato  
Di Stadio_OAS1 gene_2022.pdf

accesso aperto

Note: https://www.europeanreview.org/article/27858
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 618.98 kB
Formato Adobe PDF
618.98 kB Adobe PDF Visualizza/Apri PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11573/1636056
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 2
social impact